Administration of ketamine for unipolar and bipolar depression.
International Journal of Psychiatry in Clinical Practice March 2017 Christoph Kraus, Ulrich Rabl, Thomas Vanicek et al.
Clinical trials demonstrated that ketamine exhibits rapid antidepressant efficacy when administered in subanaesthetic dosages. We reviewed currently available literature investigating efficacy, response rates and safety profile. Twelve studies investigating unipolar, seven on bipolar depression were included after search in medline, scopus and web of science. Randomized, placebo-controlled or...
DOI: 10.1080/13651501.2016.1254802 (opens in new tab)
Full text (opens in new tab)
Ketamine
Depression
Nmda-receptor
Glutamate
+1